Rimonabant induces partial seizures in a patient with a history of generalized epilepsy.
Braakman
Hilde M H
HM
van Oostenbrugge
Robert J
RJ
van Kranen-Mastenbroek
Vivianne H J M
VH
de Krom
Marc C T F M
MC
D019440:Anti-Obesity Agents / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D063387:Cannabinoid Receptor Antagonists; D015897:Comorbidity; D004435:Eating / Q000187:drug effects; D004828:Epilepsies, Partial / Q000139:chemically induced* / Q000453:epidemiology; D004829:Epilepsy, Generalized / Q000453:epidemiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000188:drug therapy; D010880:Piperidines / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D011720:Pyrazoles / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D000077285:Rimonabant
D019440:Anti-Obesity Agents; D063387:Cannabinoid Receptor Antagonists; D010880:Piperidines; D011720:Pyrazoles; D000077285:Rimonabant